Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
Phase of Trial: Phase IV
Latest Information Update: 09 Jan 2017
Price : $35 *
At a glance
- Drugs Sitagliptin (Primary)
- Indications Diabetic foot ulcer; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 May 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 07 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Dec 2013 New trial record